Personalizing	O
lung	B:C0684249
cancer	I:C0684249
risk	O
prediction	O
and	O
imaging	O
follow	O
-	I:C1522577
up	I:C1522577
recommendations	O
using	O
the	O
National	O
Lung	I:C1298641
Screening	I:C1298641
Trial	I:C1298641
dataset	I:C1298641

Personalizing	O
lung	O
cancer	I:C0684249
risk	O
prediction	O
and	O
imaging	B:C0011923
follow	O
-	I:C1522577
up	I:C1522577
recommendations	O
using	O
the	O
National	O
Lung	I:C1298641
Screening	I:C1298641
Trial	I:C1298641
dataset	I:C1298641

Personalizing	O
lung	O
cancer	I:C0684249
risk	O
prediction	O
and	O
imaging	O
follow	B:C1522577
-	I:C1522577
up	I:C1522577
recommendations	O
using	O
the	O
National	O
Lung	I:C1298641
Screening	I:C1298641
Trial	I:C1298641
dataset	I:C1298641

Personalizing	O
lung	O
cancer	I:C0684249
risk	O
prediction	O
and	O
imaging	O
follow	O
-	I:C1522577
up	I:C1522577
recommendations	O
using	O
the	O
National	B:C1298641
Lung	I:C1298641
Screening	I:C1298641
Trial	I:C1298641
dataset	I:C1298641

To	O
demonstrate	O
a	O
data	O
-	O
driven	O
method	O
for	O
personalizing	O
lung	B:C0684249
cancer	I:C0684249
risk	O
prediction	O
using	O
a	O
large	O
clinical	I:C1298641
dataset	I:C1298641
.	O

To	O
demonstrate	O
a	O
data	O
-	O
driven	O
method	O
for	O
personalizing	O
lung	O
cancer	I:C0684249
risk	O
prediction	O
using	O
a	O
large	B:C1298641
clinical	I:C1298641
dataset	I:C1298641
.	O

An	O
algorithm	B:C0002045
was	O
used	O
to	O
categorize	O
nodules	O
found	O
in	O
the	O
first	O
screening	O
year	O
of	O
the	O
National	O
Lung	O
Screening	O
Trial	O
as	O
malignant	O
or	O
nonmalignant	O
.	O

An	O
algorithm	O
was	O
used	O
to	O
categorize	O
nodules	B:C0034079
found	O
in	O
the	O
first	O
screening	O
year	O
of	O
the	O
National	O
Lung	O
Screening	O
Trial	O
as	O
malignant	O
or	O
nonmalignant	O
.	O

An	O
algorithm	O
was	O
used	O
to	O
categorize	O
nodules	O
found	O
in	O
the	O
first	O
screening	B:C0199230
year	O
of	O
the	O
National	O
Lung	O
Screening	O
Trial	O
as	O
malignant	O
or	O
nonmalignant	O
.	O

An	O
algorithm	O
was	O
used	O
to	O
categorize	O
nodules	O
found	O
in	O
the	O
first	O
screening	O
year	O
of	O
the	O
National	O
Lung	O
Screening	O
Trial	O
as	O
malignant	B:C0006826
or	O
nonmalignant	O
.	O

An	O
algorithm	O
was	O
used	O
to	O
categorize	O
nodules	O
found	O
in	O
the	O
first	O
screening	O
year	O
of	O
the	O
National	O
Lung	O
Screening	O
Trial	O
as	O
malignant	O
or	O
nonmalignant	B:C0086692
.	O

Risk	B:C4040945
of	I:C4040945
malignancy	I:C4040945
for	O
nodules	O
was	O
calculated	O
based	O
on	O
size	O
criteria	O
according	O
to	O
the	O
Fleischner	O
Society	I:C0037459
recommendations	O
from	O
2005	O
,	O
along	O
with	O
the	O
additional	O
discriminators	I:C0439062
of	O
pack	O
-	O
years	O
smoking	O
history	O
,	O
sex	O
,	O
and	O
nodule	O
location	O
.	O

Risk	O
of	I:C4040945
malignancy	I:C4040945
for	O
nodules	B:C0034079
was	O
calculated	O
based	O
on	O
size	O
criteria	O
according	O
to	O
the	O
Fleischner	O
Society	I:C0037459
recommendations	O
from	O
2005	O
,	O
along	O
with	O
the	O
additional	O
discriminators	I:C0439062
of	O
pack	O
-	O
years	O
smoking	O
history	O
,	O
sex	O
,	O
and	O
nodule	O
location	O
.	O

Risk	O
of	I:C4040945
malignancy	I:C4040945
for	O
nodules	O
was	O
calculated	O
based	O
on	O
size	O
criteria	O
according	O
to	O
the	O
Fleischner	B:C0037459
Society	I:C0037459
recommendations	O
from	O
2005	O
,	O
along	O
with	O
the	O
additional	O
discriminators	I:C0439062
of	O
pack	O
-	O
years	O
smoking	O
history	O
,	O
sex	O
,	O
and	O
nodule	O
location	O
.	O

Risk	O
of	I:C4040945
malignancy	I:C4040945
for	O
nodules	O
was	O
calculated	O
based	O
on	O
size	O
criteria	O
according	O
to	O
the	O
Fleischner	O
Society	I:C0037459
recommendations	O
from	O
2005	O
,	O
along	O
with	O
the	O
additional	B:C0439062
discriminators	I:C0439062
of	O
pack	O
-	O
years	O
smoking	O
history	O
,	O
sex	O
,	O
and	O
nodule	O
location	O
.	O

Risk	O
of	I:C4040945
malignancy	I:C4040945
for	O
nodules	O
was	O
calculated	O
based	O
on	O
size	O
criteria	O
according	O
to	O
the	O
Fleischner	O
Society	I:C0037459
recommendations	O
from	O
2005	O
,	O
along	O
with	O
the	O
additional	O
discriminators	I:C0439062
of	O
pack	O
-	O
years	O
smoking	O
history	O
,	O
sex	O
,	O
and	O
nodule	B:C0028259
location	O
.	O

Risk	O
of	I:C4040945
malignancy	I:C4040945
for	O
nodules	O
was	O
calculated	O
based	O
on	O
size	O
criteria	O
according	O
to	O
the	O
Fleischner	O
Society	I:C0037459
recommendations	O
from	O
2005	O
,	O
along	O
with	O
the	O
additional	O
discriminators	I:C0439062
of	O
pack	O
-	O
years	O
smoking	O
history	O
,	O
sex	O
,	O
and	O
nodule	O
location	B:C0450429
.	O

Imaging	B:C0011923
follow	O
-	I:C1522577
up	I:C1522577
recommendations	O
were	O
assigned	O
according	O
to	O
Fleischner	O
size	O
category	O
malignancy	O
risk	O
.	O

Imaging	O
follow	B:C1522577
-	I:C1522577
up	I:C1522577
recommendations	O
were	O
assigned	O
according	O
to	O
Fleischner	O
size	O
category	O
malignancy	O
risk	O
.	O

Imaging	O
follow	O
-	I:C1522577
up	I:C1522577
recommendations	O
were	O
assigned	O
according	O
to	O
Fleischner	B:C0037459
size	O
category	O
malignancy	O
risk	O
.	O

Imaging	O
follow	O
-	I:C1522577
up	I:C1522577
recommendations	O
were	O
assigned	O
according	O
to	O
Fleischner	O
size	O
category	B:C0683312
malignancy	O
risk	O
.	O

Nodule	B:C0449457
size	I:C0449457
correlated	O
with	O
malignancy	O
risk	O
as	O
predicted	O
by	O
the	O
Fleischner	O
Society	I:C0037459
recommendations	O
.	O

Nodule	O
size	I:C0449457
correlated	O
with	O
malignancy	O
risk	O
as	O
predicted	O
by	O
the	O
Fleischner	B:C0037459
Society	I:C0037459
recommendations	O
.	O

With	O
the	O
additional	B:C0683312
discriminators	I:C0683312
of	O
smoking	O
history	I:C1519384
,	O
sex	O
,	O
and	O
nodule	O
location	O
,	O
significant	O
risk	O
stratification	O
was	O
observed	O
.	O

With	O
the	O
additional	O
discriminators	I:C0683312
of	O
smoking	B:C1519384
history	I:C1519384
,	O
sex	O
,	O
and	O
nodule	O
location	O
,	O
significant	O
risk	O
stratification	O
was	O
observed	O
.	O

With	O
the	O
additional	O
discriminators	I:C0683312
of	O
smoking	O
history	I:C1519384
,	O
sex	O
,	O
and	O
nodule	B:C0028259
location	O
,	O
significant	O
risk	O
stratification	O
was	O
observed	O
.	O

With	O
the	O
additional	O
discriminators	I:C0683312
of	O
smoking	O
history	I:C1519384
,	O
sex	O
,	O
and	O
nodule	O
location	B:C0450429
,	O
significant	O
risk	O
stratification	O
was	O
observed	O
.	O

With	O
the	O
additional	O
discriminators	I:C0683312
of	O
smoking	O
history	I:C1519384
,	O
sex	O
,	O
and	O
nodule	O
location	O
,	O
significant	O
risk	O
stratification	B:C1514983
was	O
observed	O
.	O

For	O
example	O
,	O
men	O
with	O
≥	O
60	O
pack	O
-	O
years	O
smoking	O
history	O
and	O
upper	B:C0034079
lobe	I:C0034079
nodules	I:C0034079
measuring	O
>	O
4	O
and	O
≤	O
6	O
mm	O
demonstrated	O
significantly	O
increased	O
risk	I:C1857701
of	I:C1857701
malignancy	I:C1857701
at	O
12.4	O
%	O
compared	O
to	O
the	O
mean	O
of	O
3.81	O
%	O
for	O
similarly	O
sized	O
nodules	I:C0449457
(	O
P	O
<	O
.0001	O
)	O
.	O

For	O
example	O
,	O
men	O
with	O
≥	O
60	O
pack	O
-	O
years	O
smoking	O
history	O
and	O
upper	O
lobe	I:C0034079
nodules	I:C0034079
measuring	O
>	O
4	O
and	O
≤	O
6	O
mm	O
demonstrated	O
significantly	O
increased	B:C1857701
risk	I:C1857701
of	I:C1857701
malignancy	I:C1857701
at	O
12.4	O
%	O
compared	O
to	O
the	O
mean	O
of	O
3.81	O
%	O
for	O
similarly	O
sized	O
nodules	I:C0449457
(	O
P	O
<	O
.0001	O
)	O
.	O

For	O
example	O
,	O
men	O
with	O
≥	O
60	O
pack	O
-	O
years	O
smoking	O
history	O
and	O
upper	O
lobe	I:C0034079
nodules	I:C0034079
measuring	O
>	O
4	O
and	O
≤	O
6	O
mm	O
demonstrated	O
significantly	O
increased	O
risk	I:C1857701
of	I:C1857701
malignancy	I:C1857701
at	O
12.4	O
%	O
compared	O
to	O
the	O
mean	O
of	O
3.81	O
%	O
for	O
similarly	O
sized	B:C0449457
nodules	I:C0449457
(	O
P	O
<	O
.0001	O
)	O
.	O

Based	O
on	O
personalized	O
malignancy	O
risk	O
,	O
54	O
%	O
of	O
nodules	B:C0028259
>	O
4	O
and	O
≤	O
6	O
mm	O
were	O
reclassified	O
to	O
longer	O
-	O
term	O
follow	O
-	O
up	O
than	O
recommended	O
by	O
Fleischner	O
.	O

Based	O
on	O
personalized	O
malignancy	O
risk	O
,	O
54	O
%	O
of	O
nodules	O
>	O
4	O
and	O
≤	O
6	O
mm	O
were	O
reclassified	O
to	O
longer	O
-	O
term	O
follow	O
-	O
up	O
than	O
recommended	O
by	O
Fleischner	B:C0037459
.	O

Twenty	O
-	O
seven	O
percent	O
of	O
nodules	B:C0028259
≤	O
4	O
mm	O
were	O
reclassified	O
to	O
shorter	O
-	O
term	O
follow	O
-	I:C1522577
up	I:C1522577
.	O

Twenty	O
-	O
seven	O
percent	O
of	O
nodules	O
≤	O
4	O
mm	O
were	O
reclassified	O
to	O
shorter	O
-	O
term	O
follow	B:C1522577
-	I:C1522577
up	I:C1522577
.	O

Using	O
available	O
clinical	B:C0150098
datasets	I:C0150098
such	O
as	O
the	O
National	O
Lung	O
Screening	O
Trial	O
in	O
conjunction	O
with	O
locally	O
collected	O
datasets	O
can	O
help	O
clinicians	O
provide	O
more	O
personalized	O
malignancy	O
risk	O
prediction	O
s	O
and	O
follow	O
-	I:C1522577
up	I:C1522577
recommendations	O
.	O

Using	O
available	O
clinical	O
datasets	I:C0150098
such	O
as	O
the	O
National	O
Lung	O
Screening	O
Trial	O
in	O
conjunction	O
with	O
locally	B:C1517927
collected	O
datasets	O
can	O
help	O
clinicians	O
provide	O
more	O
personalized	O
malignancy	O
risk	O
prediction	O
s	O
and	O
follow	O
-	I:C1522577
up	I:C1522577
recommendations	O
.	O

Using	O
available	O
clinical	O
datasets	I:C0150098
such	O
as	O
the	O
National	O
Lung	O
Screening	O
Trial	O
in	O
conjunction	O
with	O
locally	O
collected	O
datasets	B:C0150098
can	O
help	O
clinicians	O
provide	O
more	O
personalized	O
malignancy	O
risk	O
prediction	O
s	O
and	O
follow	O
-	I:C1522577
up	I:C1522577
recommendations	O
.	O

Using	O
available	O
clinical	O
datasets	I:C0150098
such	O
as	O
the	O
National	O
Lung	O
Screening	O
Trial	O
in	O
conjunction	O
with	O
locally	O
collected	O
datasets	O
can	O
help	O
clinicians	B:C0871685
provide	O
more	O
personalized	O
malignancy	O
risk	O
prediction	O
s	O
and	O
follow	O
-	I:C1522577
up	I:C1522577
recommendations	O
.	O

Using	O
available	O
clinical	O
datasets	I:C0150098
such	O
as	O
the	O
National	O
Lung	O
Screening	O
Trial	O
in	O
conjunction	O
with	O
locally	O
collected	O
datasets	O
can	O
help	O
clinicians	O
provide	O
more	O
personalized	O
malignancy	O
risk	O
prediction	O
s	O
and	O
follow	B:C1522577
-	I:C1522577
up	I:C1522577
recommendations	O
.	O

By	O
incorporating	O
3	O
demographic	O
data	O
points	O
,	O
the	O
risk	B:C4040945
of	I:C4040945
lung	I:C4040945
nodule	I:C4040945
malignancy	I:C4040945
within	O
the	O
Fleischner	O
categories	O
can	O
be	O
considerably	O
stratified	O
and	O
more	O
personalized	O
follow	O
-	I:C1522577
up	I:C1522577
recommendations	O
can	O
be	O
made	O
.	O

By	O
incorporating	O
3	O
demographic	O
data	O
points	O
,	O
the	O
risk	O
of	I:C4040945
lung	I:C4040945
nodule	I:C4040945
malignancy	I:C4040945
within	O
the	O
Fleischner	B:C0037459
categories	O
can	O
be	O
considerably	O
stratified	O
and	O
more	O
personalized	O
follow	O
-	I:C1522577
up	I:C1522577
recommendations	O
can	O
be	O
made	O
.	O

By	O
incorporating	O
3	O
demographic	O
data	O
points	O
,	O
the	O
risk	O
of	I:C4040945
lung	I:C4040945
nodule	I:C4040945
malignancy	I:C4040945
within	O
the	O
Fleischner	O
categories	B:C0683312
can	O
be	O
considerably	O
stratified	O
and	O
more	O
personalized	O
follow	O
-	I:C1522577
up	I:C1522577
recommendations	O
can	O
be	O
made	O
.	O

By	O
incorporating	O
3	O
demographic	O
data	O
points	O
,	O
the	O
risk	O
of	I:C4040945
lung	I:C4040945
nodule	I:C4040945
malignancy	I:C4040945
within	O
the	O
Fleischner	O
categories	O
can	O
be	O
considerably	O
stratified	O
and	O
more	O
personalized	O
follow	B:C1522577
-	I:C1522577
up	I:C1522577
recommendations	O
can	O
be	O
made	O
.	O

